168.55

1.95% -3.35

Quest Diagnostics Inc (DGX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Quest Diagnostics Inc stock is traded at $168.55, with a volume of 1.88M. It is down -1.95% in the last 24 hours and down -5.65% over the past month. Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Previous Close:

$171.90

Open:

$172.6

24h Volume:

1.88M

Relative Volume:

1.63

Market Cap:

$18.82B

Revenue:

$9.54B

Net Income/Loss:

$841.00M

P/E Ratio:

22.65

EPS:

7.44

Net Cash Flow:

$1.02B

1W Performance:

+0.98%

1M Performance:

-5.65%

6M Performance:

+8.55%

1Y Performance:

+16.85%

1-Day Range:

$167.16

$173.04

1-Week Range:

$165.30

$178.86

52-Week Range:

$140.71

$182.38

Quest Diagnostics Inc Stock (DGX) Company Profile

Name

Quest Diagnostics Inc

Sector

Healthcare (1163)

Industry

Diagnostics & Research (54)

Phone

(973) 520-2700

Address

500 PLAZA DRIVE, SECAUCUS

Employee

56,000

Twitter

@QuestDX

Next Earnings Date

2025-07-22

Latest SEC Filings

DGX's Discussions on Twitter

Compare DGX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DGX Quest Diagnostics Inc	168.55	19.22B	9.54B	841.00M	1.02B	7.44
TMO Thermo Fisher Scientific Inc	478.32	179.32B	43.21B	6.58B	6.17B	17.29
DHR Danaher Corp	205.48	145.22B	24.01B	3.41B	4.86B	4.70
IDXX Idexx Laboratories Inc	565.19	44.23B	3.93B	894.97M	837.70M	10.82
IQV Iqvia Holdings Inc	199.17	34.14B	15.50B	1.33B	2.16B	7.34
A Agilent Technologies Inc	120.18	34.19B	6.63B	1.17B	1.19B	4.05

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-02-25	Initiated	Redburn Atlantic	Buy
Mar-04-25	Downgrade	Citigroup	Buy → Neutral
Jan-06-25	Upgrade	Leerink Partners	Market Perform → Outperform
Dec-17-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-10-24	Resumed	Jefferies	Buy
Oct-23-24	Upgrade	Robert W. Baird	Neutral → Outperform
Aug-28-24	Resumed	Evercore ISI	In-line
Jul-10-24	Upgrade	Citigroup	Neutral → Buy
Feb-26-24	Initiated	Leerink Partners	Market Perform
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jan-03-24	Initiated	Barclays	Equal Weight
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Jun-29-23	Initiated	Piper Sandler	Neutral
May-02-23	Downgrade	BofA Securities	Buy → Neutral
Apr-03-23	Upgrade	Citigroup	Sell → Neutral
Jan-23-23	Initiated	Evercore ISI	In-line
Nov-17-22	Downgrade	Citigroup	Neutral → Sell
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Apr-04-22	Downgrade	Citigroup	Buy → Neutral
Feb-23-22	Downgrade	UBS	Buy → Neutral
Feb-02-22	Downgrade	Jefferies	Buy → Hold
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold
May-04-21	Upgrade	UBS	Neutral → Buy
Mar-12-21	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-21-20	Upgrade	Argus	Hold → Buy
Jul-29-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Jul-14-20	Upgrade	BofA Securities	Neutral → Buy
Jun-09-20	Upgrade	Wells Fargo	Underweight → Equal Weight
Jun-02-20	Upgrade	Deutsche Bank	Hold → Buy
Apr-28-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-27-20	Upgrade	Citigroup	Neutral → Buy
Apr-27-20	Upgrade	Wolfe Research	Underperform → Peer Perform
Mar-27-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-08-20	Initiated	Wells Fargo	Underweight
Jan-07-20	Downgrade	Barclays	Overweight → Equal Weight
Dec-19-19	Upgrade	BofA/Merrill	Underperform → Neutral
Jul-15-19	Downgrade	Goldman	Neutral → Sell
Apr-02-19	Upgrade	Jefferies	Hold → Buy
Mar-18-19	Resumed	Credit Suisse	Neutral
Jan-31-19	Downgrade	Argus	Buy → Hold
Jan-17-19	Initiated	UBS	Neutral
Jan-03-19	Downgrade	BofA/Merrill	Neutral → Underperform
Dec-03-18	Downgrade	BofA/Merrill	Buy → Neutral
Nov-30-18	Downgrade	Goldman	Buy → Neutral

View All

Quest Diagnostics Inc Stock (DGX) Latest News

Jul 27, 2025

What catalysts could drive Quest Diagnostics Incorporated stock higher in 2025Sky-high profits - jammulinksnews.com

Jul 27, 2025

Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Quest Diagnostics (NYSE:DGX) Stock Price - MarketBeat

Jul 27, 2025

Jul 25, 2025

Quest Diagnostics Incorporated Stock Analysis and ForecastPhenomenal capital gains - PrintWeekIndia

Jul 25, 2025

What analysts say about Quest Diagnostics Incorporated stockDynamic growth stocks - PrintWeekIndia

Jul 25, 2025

How high can Quest Diagnostics Incorporated stock price go in 2025High-performance investment picks - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

Quest Diagnostics Trading Volume Drops 31.43% to $364 Million Ranking 317th Despite Stock Price Rise - AInvest

Jul 24, 2025

Options Corner: Quest Diagnostics' Post-Earnings Digestion Drama Opens A Science-Backed Opportunity - inkl

Jul 24, 2025

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - ADVFN Brasil

Jul 23, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 23, 2025

Quest Diagnostics (DGX) Price Target Raised by Deutsche Bank | D - GuruFocus

Jul 23, 2025

Is Quest Diagnostics Incorporated a good long term investmentConsistently exceptional gains - Autocar Professional

Jul 23, 2025

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MSN

Jul 23, 2025